What is he best known for?
The fields of study he is best known for:
- Gene
- Biochemistry
- Organic chemistry
Kun Na spends much of his time researching Biophysics, Biochemistry, Photosensitizer, Drug carrier and Nanoparticle.
His Biophysics research integrates issues from Extracellular, Paclitaxel and Micelle.
His Micelle research incorporates themes from Copolymer, Ethylene glycol, Polymer chemistry, Doxorubicin and Stereochemistry.
The study incorporates disciplines such as Conjugated system, Cancer cell, Photodynamic therapy and HeLa in addition to Photosensitizer.
His studies in Drug carrier integrate themes in fields like Liberation, Dynamic light scattering, Dosage form and Cytotoxicity.
His research in Nanoparticle intersects with topics in Curdlan, Pyrene, Polymer and Nuclear chemistry.
His most cited work include:
- Polymeric micelle for tumor pH and folate-mediated targeting. (522 citations)
- Super pH-sensitive multifunctional polymeric micelle. (504 citations)
- Doxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumor. (474 citations)
What are the main themes of his work throughout his whole career to date?
Kun Na mainly investigates Photosensitizer, Photodynamic therapy, Drug delivery, Biochemistry and Biophysics.
His Photosensitizer research includes elements of Pheophorbide A, Conjugated system and Phototoxicity.
His Photodynamic therapy research is multidisciplinary, relying on both Combinatorial chemistry, Cancer, Cancer research and Nanotechnology.
His research on Drug delivery focuses in particular on Drug carrier.
He has included themes like Chondroitin sulfate, Dynamic light scattering and Dosage form in his Drug carrier study.
His Biophysics study also includes fields such as
- Micelle which is related to area like Stereochemistry,
- In vitro which connect with Cationic polymerization.
He most often published in these fields:
- Photosensitizer (20.51%)
- Photodynamic therapy (19.23%)
- Drug delivery (16.67%)
What were the highlights of his more recent work (between 2016-2021)?
- Photodynamic therapy (19.23%)
- Cancer research (12.82%)
- Photosensitizer (20.51%)
In recent papers he was focusing on the following fields of study:
His main research concerns Photodynamic therapy, Cancer research, Photosensitizer, In vitro and Immunotherapy.
The various areas that Kun Na examines in his Photodynamic therapy study include Cancer, Cancer therapy, Conjugated system, Drug delivery and Combinatorial chemistry.
Kun Na has researched Cancer research in several fields, including Pancreatic cancer, Cancer cell, Immune system, Stem cell and Cytotoxicity.
He undertakes multidisciplinary studies into Photosensitizer and Conjugate in his work.
His In vitro research includes themes of Biophysics and Hyaluronic acid.
His Doxorubicin study integrates concerns from other disciplines, such as Cardiotoxicity, Implant and Micelle.
Between 2016 and 2021, his most popular works were:
- Thermo-sensitive injectable hydrogel based on the physical mixing of hyaluronic acid and Pluronic F-127 for sustained NSAID delivery. (83 citations)
- Combination of photodynamic therapy (PDT) and anti-tumor immunity in cancer therapy. (56 citations)
- Combination of chemotherapy and photodynamic therapy for cancer treatment with sonoporation effects. (39 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Organic chemistry
- Biochemistry
The scientist’s investigation covers issues in Photodynamic therapy, Cancer research, Photosensitizer, Drug delivery and Immune system.
The concepts of his Photodynamic therapy study are interwoven with issues in Conjugated system, Magnetic resonance imaging and Magnetic nanoparticles.
Kun Na usually deals with Conjugated system and limits it to topics linked to Lipoic acid and Biophysics.
His Photosensitizer research is multidisciplinary, incorporating elements of Cancer cell, Apoptosis and Liposome.
His Drug delivery study combines topics from a wide range of disciplines, such as Cancer, Pharmacokinetics, Doxorubicin, Nanomedicine and Aqueous solution.
Kun Na combines subjects such as In vitro and Combination therapy with his study of Doxorubicin.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
